Neuropharmacology & Neurotherapeutics
Coenzyme Q10
Sep. 04, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Brain MRI at the age of 18 years, 6 years after initial attack. (B1) T2-weighted axial MRI showing a new large frontal lesion associated with edema and surrounding hypointense rim. (B2) T1-weighted axial MRI with gadolinium at same level as B1 showing ring enhancement. (B3 and B4) T1- and T2-weighted axial MRI images showing near complete resolution of the lesion. (Contributed by Dr. Claudia Lucchinetti.)